• Share
  • Email
  • Print
Get Connected
IP Litigation Alert

Antibody Patents Are Not Immune to § 112: Amgen Inc. v. Sanofi, Aventisub LLC

Trevor M. Gates, Christopher B. Roberts, Jackson Ho
14 December 2017

This publication/newsletter is for informational purposes and does not contain or convey legal advice. The information herein should not be used or relied upon in regard to any particular facts or circumstances without first consulting a lawyer. Any views expressed herein are those of the author(s) and not necessarily those of the law firm’s clients.